Humana (HUM): Today's Featured Health Care Loser

Humana ( HUM) pushed the Health Care sector lower today making it today's featured Health Care loser. The sector as a whole closed the day down 0.4%. By the end of trading, Humana fell $7.14 (-8.1%) to $80.68 on heavy volume. Throughout the day, 7.3 million shares of Humana exchanged hands as compared to its average daily volume of 1.7 million shares. The stock ranged in price between $79.60-$83.90 after having opened the day at $82.98 as compared to the previous trading day's close of $87.82. Other company's within the Health Care sector that declined today were: Hologic ( HOLX), down 9.9%, Five Star Quality Care Incorporated ( FVE), down 9%, NeurogesX ( NGSX), down 8.8%, and Biodel ( BIOD), down 7.7%.

Humana Inc. operates as a health care company that offers a range of insurance products and health and wellness services that incorporate an integrated approach to lifelong well-being. Humana has a market cap of $14.62 billion and is part of the health services industry. Currently there are 12 analysts that rate Humana a buy, no analysts rate it a sell, and eight rate it a hold.

TheStreet Ratings rates Humana as a buy. The company's strengths can be seen in multiple areas, such as its compelling growth in net income, revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance and attractive valuation levels. We feel these strengths outweigh the fact that the company shows weak operating cash flow.

On the positive front, Conceptus ( CPTS), up 23.6%, Warner Chilcott ( WCRX), up 16.1%, NuPathe ( PATH), up 15.3%, and China Shenghuo Pharmaceutical Holdings ( KUN), up 13.5%, were all gainers within the health care sector with Amylin Pharmaceuticals ( AMLN) being today's featured health care sector winner.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).
null

If you liked this article you might like

Why a Walgreens Purchase of Humana or WellCare Now Appears Less Likely

Why a Walgreens Purchase of Humana or WellCare Now Appears Less Likely

Why Centene Is One of Jim Cramer's 'Absolute Favorite Stocks'

Why Centene Is One of Jim Cramer's 'Absolute Favorite Stocks'

Wall Street Volatility, Disney, Snap and Steve Wynn - 5 Things You Must Know

Wall Street Volatility, Disney, Snap and Steve Wynn - 5 Things You Must Know

Investors Are Trying to Figure Out the 'Powell Put'

Investors Are Trying to Figure Out the 'Powell Put'

Bullish Humana Stock Should Keep 'HUM'ming Along

Bullish Humana Stock Should Keep 'HUM'ming Along